Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (RBR-9qv5gd7) titled 'Metabolic profile and autonomic and cardiovascular recovery in hypertensive individuals under the acute effect of resveratrol' on Oct. 5.
Study Type: Intervention
Primary Sponsor: Fundacão Universidade de Pernambuco
Condition:
Hypertension
C23.550.291.500
Intervention:
This is a randomized, double-blind, crossover, placebo-controlled clinical study. A total of 25 volunteers will be allocated to the following treatment protocols: Protocol I) Placebo (600 mg of starch for 15 days) or Protocol II) Experimental (Resveratrol, 600 mg for 15 days). The capsules will be identical so that neither the researcher nor t...